Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Curachem

Curachem
2009 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$8.57M LATEST DEAL AMOUNT
3 INVESTORS
Description

Provider of custom synthesis of 14C radiolabeled, 3H radiolabeled and stable-isotope labelled compounds. The company's isotope synthesis specialises in 14C and 3H non-GMP radiolabelling and stable isotope labelling and produces radiolabelled and stable isotope labelled compounds, enabling global customers to meet their requirements in order to reduce cost and increase productivity.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Commercial Services
Primary Office
  • 207, Osongsaengmyeong 1-ro
  • Osong-eup, Heungdeok-gu
  • Cheongju-si, Chungcheongbuk-do 28161
  • South Korea

+82 000-000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Curachem’s full profile, request a free trial.

Curachem Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series A) 01-Jul-2016 $8.57M 000.00 Completed Generating Revenue
1. Later Stage VC 22-Dec-2015 000 000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Curachem Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Soorim Venture Capital Venture Capital Minority 000 0000 000000 0
DSC Investment Venture Capital Minority 000 0000 000000 0
Partners Investment Venture Capital Minority 000 0000 000000 0

Curachem Executive Team (3)

Name Title Board
Seat
Contact
Info
Sook Shin Chief Executive Officer & President
Hyo Im Chief Financial Officer
Yun Kim Ph.D Chief Technology Officer & Vice President